Patient Guide: ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 17 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04044859
Status: ACTIVE_NOT_RECRUITING
Condition: Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ), Gastric (Stomach) Cancer, Head and Neck Cancer, Melanoma, Ovarian Cancer, Non-small Cell Lung (NSCLC), Urothelial Cancer
Phase: PHASE1

Find a Study Location Near You

This study is available at 17 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Orlando, Florida
  • Boston, Massachusetts
  • Saint Louis, Missouri
  • • And 14 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily